Han X - Search Results

1

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

Oaknin A, Gilbert L, Tinker AV, Brown J, Mathews C, Press J, Sabatier R, O'Malley DM, Samouelian V, Boni V, Duska L, Ghamande S, Ghatage P, Kristeleit R, Leath C III, Guo W, Im E, Zildjian S, Han X, Duan T, Veneris J, Pothuri B. Oaknin A, et al. Among authors: han x. J Immunother Cancer. 2022 Jan;10(1):e003777. doi: 10.1136/jitc-2021-003777. J Immunother Cancer. 2022. PMID: 35064011 Free PMC article. Clinical Trial.

2

XH1--a new cervical carcinoma cell line and xenograft model of tumour invasion, 'metastasis' and regression.

Han X, Lyle R, Eustace DL, Jewers RJ, Parrington JM, Das A, Chana T, Dagg B, Money S, Bates TD, et al. Han X, et al. Br J Cancer. 1991 Oct;64(4):645-54. doi: 10.1038/bjc.1991.376. Br J Cancer. 1991. PMID: 1911212 Free PMC article.

3

SR8--the establishment and characterisation of a new ovarian carcinoma cell line and xenograft model.

Han X, Papadopoulos AJ, Jones TA, Sheer D, Raju KS. Han X, et al. Eur J Cancer. 1996 Jan;32A(1):160-7. doi: 10.1016/0959-8049(95)00549-8. Eur J Cancer. 1996. PMID: 8695226

4

Cholera toxin-induced alteration of the phenotype and behaviour of an ovarian carcinoma cell line, SR8.

Han X, Papadopoulos AJ, Jones T, Devaja O, Raju KS. Han X, et al. Immunol Cell Biol. 1999 Oct;77(5):377-84. doi: 10.1046/j.1440-1711.1999.00840.x. Immunol Cell Biol. 1999. PMID: 10540202

5

Tumor lymphocytes in patients with advanced ovarian cancer: changes during in vitro culture and implications for immunotherapy.

Han X, Papadopoulos AJ, Ruparelia V, Devaja O, Raju KS. Han X, et al. Gynecol Oncol. 1997 Jun;65(3):391-8. doi: 10.1006/gyno.1997.4668. Gynecol Oncol. 1997. PMID: 9190963

6

Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro.

Eustace D, Han X, Gooding R, Rowbottom A, Riches P, Heyderman E. Eustace D, et al. Among authors: han x. Gynecol Oncol. 1993 Jul;50(1):15-9. doi: 10.1006/gyno.1993.1156. Gynecol Oncol. 1993. PMID: 8349158

7

TDM35--a new monoclonal antibody to the XH1 cervical carcinoma cell line. Characterization and immunoperoxidase localization in benign and malignant tissues.

Chana T, Han X, Dagg B, Lawrie AS, Gooding RP, Eustace DL, Fletcher CD, Heyderman E. Chana T, et al. Among authors: han x. J Pathol. 1992 Aug;167(4):391-7. doi: 10.1002/path.1711670408. J Pathol. 1992. PMID: 1403358

8

Induction of immunocellular resistance to IL-2-activated lymphocytes within ovarian carcinoma cells.

Papadopoulos AJ, Han X, Matossian-Rogers A, Raju KS. Papadopoulos AJ, et al. Among authors: han x. Gynecol Oncol. 1995 Jun;57(3):388-94. doi: 10.1006/gyno.1995.1160. Gynecol Oncol. 1995. PMID: 7774843

9

IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.

Han X, Wilbanks GD, Devaja O, Ruperelia V, Raju KS. Han X, et al. Gynecol Oncol. 1999 Nov;75(2):198-210. doi: 10.1006/gyno.1999.5557. Gynecol Oncol. 1999. PMID: 10525372

10

Cytoblock preparations for examination of cervical and other cells.

Dagg B, Eustace DL, Han X, Money S, Heyderman E. Dagg B, et al. Among authors: han x. J Clin Pathol. 1992 Dec;45(12):1122-3. doi: 10.1136/jcp.45.12.1122. J Clin Pathol. 1992. PMID: 1479045 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,040 results

Search Page

Filters